BVS - Bioventus Inc.
Bioventus Inc.
4721 Emperor Boulevard
Suite 100
Durham, NC 27703
United States
919 474 6700
https://www.bioventus.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 1.040
Figure dirigenziali chiave
| Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
|---|---|---|---|---|
| Mr. Mark L. Singleton | Sr. VP & CFO | 444,12k | N/D | 1970 |
| Mr. Anthony P. Bihl III | Interim CEO & Director | N/D | N/D | 1956 |
| Mr. David Crawford | VP of Investor Relations & Treasurer | N/D | N/D | N/D |
| Mr. Anthony D'Adamio | Sr. VP, Gen. Counsel & Corp. Sec. | N/D | N/D | 1961 |
| Ms. Katrina J. Church J.D. | Sr. VP & Chief Compliance Officer | N/D | N/D | 1962 |
| Mr. Larry Chen | Managing Director of China & Asia Pacific | N/D | N/D | N/D |
| Ms. Sharon W. Klugewicz | Sr. VP of Quality & Regulatory Affairs | N/D | N/D | 1968 |
Descrizione
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for precise bone sculpting, removing tumors, and tissue debridement. The company's restorative therapies include a bone healing system; skin allografts; and products that are used to support healing of wounds, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Governance aziendale
L'ISS Governance QualityScore di Bioventus Inc. al 1 giugno 2023 è 8. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 6; diritti degli azionisti: 6; retribuzione: 9.
